Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Morningside Venture Investments Ltd
10% owner at Apnimed · 10% owner at Amylyx Pharmaceuticals. Filing since 11 Jan 2022.
CIK 0001543112
APMD
Apnimed, Inc.
10% owner · 1 trade
AMLX
Amylyx Pharmaceuticals, Inc.
10% owner · 11 trades
Company
Date
Role
Action
Shares
Amount
Of holding
APMD
Apnimed, Inc.
3 Aug 2026
10% owner
Bought
312,500
$5.00M
4.6%
AMLX
Amylyx Pharmaceuticals, Inc.
29 Mar 2023
10% owner
Sold at will
29,048
$884.51K
0.4%
AMLX
Amylyx Pharmaceuticals, Inc.
28 Mar 2023
10% owner
Sold at will
100,000
$3.04M
1.4%
AMLX
Amylyx Pharmaceuticals, Inc.
27 Mar 2023
10% owner
Sold at will
60,964
$1.86M
0.8%
AMLX
Amylyx Pharmaceuticals, Inc.
21 Mar 2023
10% owner
Sold at will
63,448
$2.02M
0.9%
AMLX
Amylyx Pharmaceuticals, Inc.
16 Mar 2023
10% owner
Sold, plan not stated
9,122
$296.92K
0.1%
AMLX
Amylyx Pharmaceuticals, Inc.
15 Mar 2023
10% owner
Sold, plan not stated
150,000
$4.99M
2.0%
AMLX
Amylyx Pharmaceuticals, Inc.
14 Mar 2023
10% owner
Sold, plan not stated
70,714
$2.44M
0.9%
AMLX
Amylyx Pharmaceuticals, Inc.
2 Mar 2023
10% owner
Sold, plan not stated
50,000
$1.69M
0.7%
AMLX
Amylyx Pharmaceuticals, Inc.
23 Feb 2023
10% owner
Sold, plan not stated
50,000
$1.78M
0.7%
AMLX
Amylyx Pharmaceuticals, Inc.
22 Feb 2023
10% owner
Sold, plan not stated
100,000
$3.54M
1.3%
AMLX
Amylyx Pharmaceuticals, Inc.
11 Jan 2022
10% owner
Bought
263,158
$5.00M
2.5%
12 decisions on file.
